Zdrowie i gospodarka · 12/07/2022
FDA Extends Comment Period for Drug Shortage Risk Management Plans
The Food and Drug Administration is extending the comment period for its draft guidance on mitigating drug shortages, in response to requests from interested persons for additional time to submit comments.
Source: Federal Register — Food and Drug AdministrationOpen original release →